RE: technical analysis updatePlexor,
Just wanted to start by saying... never invest more money in a stock than you can afford to lose.
Having said that, if you are getting jittery, you could always sell 1/2 your shares before news comes out to protect yourself.
However, and I don't mean to be harsh, but you really have to spend some time thinking about why you invested in Conjuchem in the first place. I did so because I believe they have the potential for a best in class diabetes treatment, the market for which, based on my research, UNFORTUNATELY!! will continue to grow at an alarming rate. The market is so robust that the valuation models that the analysts are using to come to their price targets suggest earnings of $2.XX in years ahead once the product goes to market. (To say nothing of the other products in their pipeline.)
Now, I spoke with investor relations in order to raise my comfort level that the two trials currently underway (or finished for all I know) can reasonable be expected resolve the problem of nausea. If that proves out in the next couple weeks, I genuinely see no reason why the stock wouldn't return to it's previous double digit levels.
Cheers,
Cpac.